Concepedia

Kirk P. Van Ness

KP

Statistics

Publications

8

Citations

877

H-Index

8

Active since

1984

Affiliations

University of Washington(Current)

Nortis (United States)

Sarepta Therapeutics (United States)

MPI Research (United States)

Kirk P. Van Ness is an author at University of Washington specializing in toxicology, pharmacy, and biochemistry.

Publications per year

1984–2017

8

Publications

8

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography

David R. Eyre, Thomas J. Koob, Kirk P. Van Ness · Analytical Biochemistry · 1984 · 659 citations

, , +8

Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy

Peter Sazani, Kirk P. Van Ness, Doreen L. Weller et al. · International Journal of Toxicology · 2011 · 49 citations

, , +17

Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity

Shih‐Yu Chang, Jenna L. Voellinger, Kirk P. Van Ness et al. · Toxicology in Vitro · 2017 · 45 citations

, , +14

Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in <i>mdx</i> Mice

Peter Sazani, Kirk P. Van Ness, Doreen L. Weller et al. · International Journal of Toxicology · 2011 · 31 citations

, , +15

Differential epigenetic effects of chlorpyrifos and arsenic in proliferating and differentiating human neural progenitor cells

Hee Yeon Kim, Susanna Wegner, Kirk P. Van Ness et al. · Reproductive Toxicology · 2016 · 27 citations · Full text

, , +14

1–5 of 8